BeiGene/LinkedIn
Nov 16, 2024, 11:27
John V. Oyler: Committed to uniting the global community against cancer as BeOne
John V. Oyler, Founder, Chairman & CEO at BeiGene, shared a post by BeiGene on LinkedIn, adding the following:
“We must all work together, which is why we are committed to uniting the global community against cancer as BeOne. Learn more about our proposed company name change by reading the press release below.”
Quoting BeiGene’s post:
“Today we unveiled our proposed name change to BeOne Medicines Ltd. Reaffirming our mission to unite the global community against cancer. Read the press release for full details.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 20, 2025, 02:27
Apr 19, 2025, 22:24
Apr 19, 2025, 22:03
Apr 19, 2025, 21:39
Apr 19, 2025, 21:21
Apr 19, 2025, 21:04
Apr 19, 2025, 20:48
Apr 19, 2025, 20:25
Apr 19, 2025, 19:36
Apr 19, 2025, 19:17